C07D 281/00
Heterocyclic compounds containing rings of more than six members having one nitrogen
Official title: Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
C07D281/00 (Heterocyclic compounds containing rings of more than six members having one nitrogen) appears on 462 US grants and 335 published applications in this corpus.
Search patents in C07D- Granted patents
- 462
- Published applications
- 335
- Assignees
- 250
- Inventors
- 1,235
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 4 | 0 |
| 1981 | 5 | 0 |
| 1982 | 5 | 0 |
| 1983 | 3 | 0 |
| 1984 | 5 | 0 |
| 1985 | 8 | 0 |
| 1986 | 14 | 0 |
| 1987 | 9 | 0 |
| 1988 | 7 | 0 |
| 1989 | 6 | 0 |
| 1990 | 11 | 0 |
| 1991 | 14 | 0 |
| 1992 | 14 | 0 |
| 1993 | 15 | 0 |
| 1994 | 13 | 0 |
| 1995 | 13 | 0 |
| 1996 | 16 | 0 |
| 1997 | 19 | 0 |
| 1998 | 19 | 0 |
| 1999 | 20 | 0 |
| 2000 | 12 | 0 |
| 2001 | 4 | 3 |
| 2002 | 18 | 14 |
| 2003 | 10 | 10 |
| 2004 | 5 | 13 |
| 2005 | 9 | 9 |
| 2006 | 6 | 16 |
| 2007 | 10 | 18 |
| 2008 | 4 | 18 |
| 2009 | 5 | 18 |
| 2010 | 13 | 19 |
| 2011 | 12 | 14 |
| 2012 | 6 | 9 |
| 2013 | 11 | 9 |
| 2014 | 10 | 17 |
| 2015 | 8 | 9 |
| 2016 | 8 | 15 |
| 2017 | 9 | 11 |
| 2018 | 4 | 15 |
| 2019 | 14 | 20 |
| 2020 | 8 | 10 |
| 2021 | 16 | 15 |
| 2022 | 7 | 15 |
| 2023 | 7 | 16 |
| 2024 | 8 | 8 |
| 2025 | 8 | 11 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Salts of neuroceuticals and uses thereof25 Aug 2026US 12,714,711 B2SyneuRx International (Taiwan) Corp.
- Benzonitric heterocyclic compound, preparation method therefor and use thereof18 Aug 2026US 12,709,600 B2Shanghai Institute of Pharmaceutical Industry
- 15-PGDH inhibitor17 Mar 2026US 12,577,217 B2Kyorin Pharmaceutical Co., Ltd.
- Imaging histone deacetylases with a radiotracer using positron emission tomography9 Dec 2025US 12,491,270 B2The General Hospital Corporation
- Ring closing synthesis of macrocyclic MCL-1 inhibitor intermediates14 Oct 2025US 12,441,741 B2Amgen Inc.
- Slack-activating compounds and their medical use3 Sep 2026US 2026/0258003 A1
- Benzothia(di)azepine compounds and their use as bile acid modulators28 May 2026US 2026/0146032 A1Albireo AB
- Small molecule inhibitors of the ribosome biogenesis factor NVL29 Apr 2026US 2026/0097047 A1Board of Regents, The University of Texas System
- C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same6 Nov 2025US 2025/0340521 A1Pontificia Universidad Catolica De Chile
- Benzothia(di)azepine compounds and their use as bile acid modulators30 Oct 2025US 2025/0333390 A1Albireo AB
Most cited
By later US patents
- Condensed heterocyclic compounds154US 5,037,825 AHoffmann-La Roche Inc. · 1991
- Benzo-fused lactams that promote the release of growth hormone109US 5,206,235 AMerck & Co., Inc. · 1993
- Benzo-fused lactams promote release of growth hormone103US 5,283,241 AMerck & Co., Inc. · 1994
- Pyridopyrrolo benzheterocycles97US 4,238,607 AEndo Laboratories, Inc. · 1980
- 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use86US 6,277,831 B1Aventis Pharma Deutschland GmbH · 2001